Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. 4 Open-market sale 10% owner sold 164,488 shares at an average $8.07 ($1,327,684)
  2. 4 Open-market sale President and COO sold 7,303 shares at an average $112.86 ($824,190)
  3. SC TO-C Deal Written Communication Relating to an Issuer
  4. SC TO-C Deal Written Communication Relating to an Issuer
  5. 8-K Event Material agreement
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 4 Option exercise Chief Executive Officer acquired 4,315 shares (option exercise)
  9. 4 Other acquisition SVP, Gen. Counsel & Secretary acquired 238 shares (other)
  10. 4 Other acquisition EVP,Finance & Strategy and CFO acquired 238 shares (other)
  11. CT ORDER Other Confidential Order
  12. 4 Grant or award Director acquired 831 shares (grant or award)
  13. 4 Grant or award Director acquired 831 shares (grant or award)
  14. 4 Grant or award Director acquired 831 shares (grant or award)
  15. 4 Grant or award Director acquired 831 shares (grant or award)
  16. 4 Grant or award Director acquired 831 shares (grant or award)
  17. 4 Grant or award Director acquired 831 shares (grant or award)
  18. 4 Grant or award Director acquired 831 shares (grant or award)
  19. 4 Grant or award Director acquired 831 shares (grant or award)
  20. 8-K Event Shareholder vote results

Page 29 of 115 · 2,300 filings